Quality of Life, Cost-effectiveness of Radioiodine Ablation in Thyroid Cancer AssessedLourdes Briz
treatmentvalue-basedradioiodine refractorydifferentiated thyroid cancerBackground: Lenvatinib (Lenvima (R)) and sorafenib (Nexavar (R)) are the two most recently Food and Drug Administration-approved drugs for treating radioiodine-refractory differentiated thyroid cancer (RR-DTC). Both demonstrated superior...